Syra Health Corp. (SYRA)
Pre-market:
| Previous close | 2.1400 |
| Open | 1.8000 |
| Bid | 1.4900 x 100 |
| Ask | 1.5600 x 100 |
| Day's range | 1.3500 - 1.8000 |
| 52-week range | 0.8120 - 8.3700 |
| Volume | |
| Avg. volume | 474,433 |
| Market cap | 9.97M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.6000 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 5.32 |
PR NewswireSyra Health Announces First Quarter 2024 Financial Results, Led By Strong Revenue Growth of 47%.
Syra Health Corp. (NASDAQ: SYRA), ("Syra Health" or the "Company") a healthcare technology company with a mission to improve healthcare by providing innovative services and technology solutions, announced today its financial results for the first quarter ended March 31, 2024.
- PR Newswire
Syra Health to Deliver Comprehensive Needs Assessment and Community Health Improvement Plan for Middlesex County, New Jersey
Syra Health Corp. (NASDAQ: SYRA) ("Syra Health" or the "Company"), a healthcare technology company with a mission to improve healthcare by providing innovative services and technology solutions, announced today that it has been awarded a contract to conduct a comprehensive needs assessment for residents living in Middlesex County, New Jersey, and to develop a Community Health Improvement Plan in support of those residents.
- PR Newswire
Syra Health Presents Overdose Lifeline with Mental and Behavioral Health Solutions Award
Syra Health Corp. (NASDAQ: SYRA), a healthcare technology company with a mission to improve healthcare by providing innovative services and technology solutions, announced today it has presented the nonprofit organization Overdose Lifeline with the inaugural Syra Health Mental and Behavioral Health Solutions Award.
